@JunoSeq has partnered with collaborators from all over the world to sequence & analyse 10 000 #groupBStrep#bacteria at the @sangerinstitute to help us gain a deeper understanding of the biology & inform on treatment intervention strategies #Genomics https://t.co/zgw9bjcf9D
Congratulation to the JUNO team for their new publication entitled "Genetic markers associated with host status and clonal expansion of Group B Streptococcus in the Netherlands". Learn more at https://t.co/m2MyqlP3ng
@pneumowatch@gatesfoundation@GBSSupport
Thrilled to announce our manuscript has been published! 🎉 Our study highlight the importance of comparing GBS isolates from healthy individuals and patients to identify high-risk genotypes for disease prevention and surveillance. Read more at https://t.co/vr8utlGgub @JunoSeq
Group B Strep is the UK’s leading cause of life-threatening infection in newborn babies.
Help @gbssupport to raise awareness and save babies’ lives this Group B Strep Awareness Month!
Visit https://t.co/VInX1jXipd to get informed
#GBSAM24#GBSAwareness
Exciting news! Our Brazilian JUNO partner @LabPinto just published groundbreaking research on long-term co-circulation of host-specialist and generalist GBS lineages in dairy cattle, revealing diverse antimicrobial resistance profiles. Read it here: https://t.co/hFg2tN76IZ
It’s a great collaboration with Dr. Shaper Mirza, @imran_nisar and Dr Sadia Shakoor.
Huge congratulations to my mentored @NidaJavaid_. It’s one of the achievements after series of social distanced meetings during the pandemic. Well done!
Excited to share the news that our recently published systematic review, evaluating the molecular epidemiology of the non-pregnant GBS population, is now accessible via this link (https://t.co/iBMp3LM8bK). Thanks to all collaborators for your indispensable contributions.
Dr. Uzma Khan gave a fascinating talk describing the genomic mechanisms driving antibiotic resistance in the global GBS population on the first day of ISSAD. Well done! 👏🏻
Don't miss Dr. Uzma Basit Khan's poster session on "The distribution of potential vaccine targets in global GBS population" today at ISSAD in Rio from 11.30 to 11.40 a.m, if you want to learn more about the vaccine (under development) coverage in the global GBS population.
Introducing our distinguished speaker at ISSAD 2023! 🌟
🎤 Dr. Elita Jauneikaite
📜 Talk Title: Genomic Advancements in Understanding Group B Streptococcus Disease
📢 3rd International Symposium on ‘Streptococcus agalactiae’ Disease
📅 October 16 - 18, 2023
#ISSAD2023
The International Symposium on 'Streptococcus agalactiae' Disease (#ISSAD) is looking for a host country for its 2025 conference.
Don't miss this opportunity to showcase your country's commitment to GBS research and global health. Join us in advancing the fight against #GBS!
📢 Don't miss out on the upcoming 3rd International Symposium on ‘Streptococcus Agalactiae’ Disease! 🌐
🗓️ Registration Deadline: October 13th
Secure your spot today – whether it's online or in-person!
🔬 Join us!!
https://t.co/3FUGoZ2ZP2
#ISSAD2023#GroupBStrep#ISSAD#GBS